fashion -WSS

fashion

author：fashion 2025-10-01 00:05:51 - browse：21611

Maze Therapeutics CEO Jason Coloma Courtesy

After seeing its last deal go bust in the face of regulatory scrutiny, Maze Therapeutics has found another suitor for its experimental Pompe disease treatment.

Bay Area-based Maze and Shionogi said Friday that the Japanese pharma company had licensed the drug, called MZE001, with an upfront payment of $150 million. The global deal includes additional, undisclosed payments if the oral medication, which is in clinical testing, meets certain regulatory and commercial goals.

Last year, Sanofi, the French pharma giant, was set to pay $150 million in cash and stock to Maze before the transaction fell apart.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： As Taiwan prepares for anti

explore

WSS

Stanford updates investigation of president’s past research

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

'Reaching a detente': STAT's Helen Branswell on covering Covid

Body of missing toddler recovered in Delaware River days after flood: Police

New rules on organ donation and transplantation 'will bring chaos'

explore

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Russian special forces kill a gunman who broke into a private house near Moscow

Heart attack and stroke risk calculators need revising

Marvel Studios reveals new trailer for 'The Marvels': Watch here

Trump demands the U.S. pay no more for drugs than other countries … again

Man who had jail sentence commuted by Trump arrested again

State Dept. review finds Biden bears some blame for Afghanistan failures

Marvel Studios reveals new trailer for 'The Marvels': Watch here

Trump demands the U.S. pay no more for drugs than other countries … again

Providers still hesitate to prescribe buprenorphine, study finds

knowledge

Death toll from an explosion and collapse of a Paris building in June climbs to 3

Review: 'Barbie' will hit you like a shot in the heart

Russian special forces kill a gunman who broke into a private house near Moscow

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

Stanford updates investigation of president’s past research

White House launches permanent pandemic office

hotspot

Wikipedia

explore

Wikipedia